95. FIS 2024 part 1: AMR & Bacteria

95. FIS 2024 part 1: AMR & Bacteria

Up next

130. Azole Antifungals

Flustered by fluconazole? An ignoramus on itraconazole and isavuconazole?Puzzled by Posa? VEXED BY VORI? Never fear: You can be amazed at the Azoles, just learn how to use 'em right! That's what this episode's all about! Alyssa and Jame UNITE in the first of our episodes on antif ...  Show more

129. Penicillin allergy 3: CEPH FAST

AKA Penicillin Allergy 3: Delabel Hard With A VengeanceA departure from our semi-annual penicillin allergy episode: one on cephalosporin allergy! Jame and Callum are joined by Fionnuala Cox to discuss Cephalosporin allergy in general, and the CEPH-FAST risk assessment tool in par ...  Show more

Recommended Episodes

1. ORIGINS OF VIRUSES + my lab is a cult...
So Cultured Podcast

🦠Hey guys! Welcome to the FIRST episode of SERIES 4 of the So Cultured Podcast! This series we delve into the ORIGINS- looking at science through the lens of history! In This episode we are discussing the Origins of Viruses 🦠🔬


❓Where did viruses come from? What di ...

  Show more

Episode 114: Acute Promyelocytic Leukemia (REBOOT!)
The Fellow on Call: The Heme/Onc Podcast

By popular demand, our next series that we are excited to share with you is on MDS/AML! As we prepare for the release of the first episode next week, let’s throw it back to Episode 019 in our Heme/Onc Emergencies Series and talk about APL!

Episode contents:

- How ...

  Show more

Episode 108: Colorectal Cancer Series, Pt. 10 - Metastatic Colorectal Cancer (Part 2)
The Fellow on Call: The Heme/Onc Podcast

This week, we round out our discussion on metastatic colorectal cancer, focusing on more targeted therapies for this disease. If you have not done so already, be sure to check out episode 107 for the first part of our metastatic colorectal cancer discussion.

Contents: </ ...

  Show more

Episode 073: Management of Early Stage Diffuse Large B-Cell Lymphoma (DLBCL)
The Fellow on Call: The Heme/Onc Podcast

This week, we continue our conversation about DLBCL, this time focusing our attention on the management of early stage disease.

If you have not done so, we highly recommend you listen to our ...

  Show more